Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidPaul Unger
    Ask Trek AI about this page

    Paul Unger — Billing Profile & Reimbursement Data

    NPI 1053318766 · Burlington, VT · Hematology & Oncology Physician

    Customize your policy alerts

    Sign up for Paul Unger — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Paul Unger is a hematology & oncology physician provider located in Burlington, Vermont. This profile covers 31 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationPaul Unger
    Address111 Colchester Ave
    CityBurlington
    StateVT
    ZIP05401
    TaxonomyHematology & Oncology Physician
    NPI EnumeratedJuly 7, 2005

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$744.6K
    Medicaid$0

    Key Findings

    This provider is effectively a single‑payer Medicare practice: Total Medicare revenue is $744.6K and there is no Medicaid billing on file, so Medicaid represents zero of reported revenue. The provider's NPI was enumerated on 2005-07-07 (~21 years ago), indicating long tenure in the Medicare program and an established billing history.

    Revenue is highly concentrated in a small set of services: the precomputed top 3 Medicare codes by revenue account for 71.3% of this provider's total Medicare revenue. The three revenue leaders are J9312 ($316.8K, 42.3%), J0897 ($118.6K, 15.8%), and 99214 ($98.6K, 13.2%), so these specific infusion drugs and mid‑level E/M visits dominate the practice's receipts.

    The code mix points to an infusion‑center oncology practice that also carries a significant ambulatory management load: J9312 (rituximab) and J0897 (denosumab) are infusion/ injectable oncology drugs and together account for a majority of Medicare revenue, while chemotherapy administration codes such as 96413 ($48K, 6.4%) and related add‑ons (96417, 96415) confirm active systemic therapy services. High volumes of E/M codes 99214 and 99215 also show ongoing, higher‑complexity outpatient evaluation and management of established patients.

    J9312 is a notable revenue driver but not nationally dominant: the provider billed J9312 in 5K claims for $316.8K (42.3% of Medicare revenue) and ranks #71 of 317 providers nationally (78th percentile; typical, unremarkable volume for this code), suggesting a moderate presence among oncology peers for rituximab administration rather than an outsized national market share. Similarly, J0897 appears as a typical national volume pattern with 6.2K claims and $118.6K revenue (15.8%) and a rank of #2184 of 10057 (78th percentile).

    Office visit utilization is an outlier relative to national peers: 99214 has 1.1K claims for $98.6K (13.2%) and ranks #9629 of 479517 (98th percentile; extreme outlier, far above typical national volume for this code), and 99215 has 602 claims for $80.1K (10.7%) and ranks #1188 of 145531 (99th percentile; extreme outlier, far above typical national volume). These rankings indicate unusually high volumes of moderate‑ to high‑complexity outpatient E/M visits compared with the nationwide provider pool.

    Operational and revenue risk considerations follow from the concentration in a few high‑value drug codes: J9312 alone contributes $316.8K (42.3%) and with J0897 brings drug revenue to a dominant share of the book, so changes in reimbursement or utilization of those specific agents could materially affect practice revenue. That concentration combined with the absence of Medicaid diversification (no Medicaid billing on file) makes the practice financially exposed to Medicare policy or market shifts affecting these drugs and associated infusion services.

    Beyond drugs and E/M, supportive services and routine diagnostics are present but represent a small share of revenue: lab and phlebotomy codes such as 36415 ($8.3K, 1.1%), 80053 ($8.2K, 1.1%), and 85025 ($8.1K, 1.1%) appear among the top codes at typical national percentiles, consistent with standard outpatient oncology monitoring rather than a separate lab‑driven revenue stream. Infusion supply codes like J7050 (636 claims, $636) and small per‑dose antiemetic entries (J2469) further reflect typical throughput operations supporting the infusion services.

    Claim counts indicate a high‑throughput infusion and follow‑up clinic: notable volumes include 5K claims for J9312, 6.2K claims for J0897, 1.1K claims for 99214, and 602 claims for 99215, which together portray frequent, repeat encounters and recurring drug administrations. In combination with the high E/M percentiles, this pattern suggests a practice model centered on regular infusion visits coupled with intensive outpatient management of complex oncology patients.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    31 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J9312Injection, rituximab, 10 mg4,950$60$316.8K
    J0897Injection, denosumab, 1 mg6,240$20$118.6K
    99214The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…1,070$90$98.6K
    99215The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…600$130$80.1K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…470$100$48K
    J9217Leuprolide acetate (for depot suspension), 7.5 mg90$130$11.7K
    36415In this procedure, the provider inserts a needle into a vein to collect a blood sample.1,040$10$8.3K
    80053The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.820$10$8.2K
    85025A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…1,020$10$8.1K
    96401The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.140$60$7.6K

    Showing 1–10 of 31

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    31 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J93122105,290$60$336.2K
    J08972107,020$20$130.2K
    96413110390$110$34.1K
    96367210290$20$13.6K
    J9217210100$130$13.3K
    99214696090$70$10.6K
    96401210140$60$8.9K
    96365210110$50$8.8K
    99215341040$110$7.2K
    9921385191080$50$6.7K

    Showing 1–10 of 31

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Paul Unger, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Somc Medical Care Foundation, Inc.OHFamily Medicine Physician$0$25.3M
    University Of Vermont Medical Center IncVTInternal Medicine Physician$0$17.6M
    Northeastern Vermont Regional Hospital, IncVTPrimary Care Clinic/Center$0$2.8M
    James StaffordTXRadiation Oncology Physician$1.5M$0
    Porter Hospital, IncVTFamily Medicine Physician$0$1.3M
    Dennis SandersVTMedical Oncology Physician$1.3M$0
    University Of Vermont Medical Center IncVTGeneral Acute Care Hospital$0$780.5K
    University Of Vermont Health Network Specialty Care Transport, LLCVTLand Ambulance$144K$510.7K
    Carlos TorresTXAnatomic Pathology & Clinical Pathology Physician$580.7K$0
    Brian KimVTOphthalmology Physician$488.3K$0

    Nearby Providers

    Other providers in the same ZIP code as Paul Unger, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Howard Center IncVTDevelopmentally Disabled Services Day Training Agency$0$332.2M
    Howard Center IncVTAdolescent and Children Mental Health Clinic/Center$0$130.1M
    Vermont Department Of Mental HealthVTAdult Mental Health Clinic/Center$0$105.1M
    Community Health Centers Of Burlington IncVTFederally Qualified Health Center (FQHC)$0$39.8M
    Howard Center IncVTMethadone Clinic$517.9K$35M
    Howard Center IncVTState or Local Public Health Clinic/Center$0$23.4M
    Transition IiVTCase Manager/Care Coordinator$0$17.3M
    The Dental Center At Community Health Center Of BurlingtonVTDental Clinic/Center$0$6.7M
    City Of Burlington VermontVTLand Ambulance$677.2K$4.3M
    Spectrum, Inc.VTAddiction (Substance Use Disorder) Counselor$0$2.4M

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Vermont Distribution
    Paul Unger — 8 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Vermont